All enrolled clients who acquired at the least a single dose of zosuquidar or placebo through induction ended up monitored to the occurrence of adverse events (439 clients, 219 on zosuquidar and 210 on placebo). The most typical adverse occasions were connected to the period of extended and important myelosuppression https://christz221lxg4.tnpwiki.com/user